K.J. Harrison & Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,990
Closed -$438K 179
2019
Q1
$438K Hold
2,990
0.15% 112
2018
Q4
$400K Sell
2,990
-2,000
-40% -$328K 0.24% 83
2018
Q3
$950K Sell
4,990
-1,300
-21% -$239K 0.24% 114
2018
Q2
$1.05M Sell
6,290
-80
-1% -$12.8K 0.3% 100
2018
Q1
$1.07M Sell
6,370
-16,456
-72% -$2.76M 0.35% 90
2017
Q4
$3.73M Sell
22,826
-2,560
-10% -$459K 1.26% 20
2017
Q3
$5.2M Buy
25,386
+16,024
+171% +$3.73M 1.79% 11
2017
Q2
$2.28M Buy
9,362
+3,312
+55% +$778K 0.89% 37
2017
Q1
$1.45M Buy
+6,050
New +$1.41M 0.59% 54
2016
Q3
Sell
-2,400
Closed -$554K 230
2016
Q2
$554K Buy
+2,400
New +$553K 0.3% 103

Other funds holding AGN

K.J. Harrison & Partners's AGN Position: Q2 2019 in Review

K.J. Harrison & Partners sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,990 shares — an estimated $438K sold.

K.J. Harrison & Partners first reported a position in AGN in Q2 2016 and held it in 10 quarters. The position peaked at $5.2M in Q3 2017. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • K.J. Harrison & Partners reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • K.J. Harrison & Partners sold 2,990 Allergan plc shares in Q2 2019, an estimated $438K.
  • K.J. Harrison & Partners first reported a position in Allergan plc in Q2 2016 and held it in 10 quarters.
  • K.J. Harrison & Partners's Allergan plc position peaked at $5.2M in Q3 2017.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on K.J. Harrison & Partners's 13F filing for Q2 2019, filed 5 Aug 2019.